Suven Life Sciences Limited (SUVEN.NS) NSE

167.61

-3.69(-2.15%)

Updated at December 24 03:29PM

Currency In INR

Valuation

Market Cap26.67B
Enterprise Value26.29B
P/E Ratio-17.57
PEG Ratio1.22
Price/Sales Ratio630.11
Price/Book Ratio13.24
Enterprise/Revenue628.47
Enterprise/EBITDA-17.86

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-36.14
Operating Margin-37.37

Management Effectiveness

Return On Assets-0.63
Return On Equity-1.22

Income Statement

Revenue66.56M
Revenue/Share0.26
Gross Profit-276.33M
EBITDA-1.55B
Net Income-1.61B
Diluted EPS-7.36

Balance Sheet

Total Cash2.59B
Total Cash/Share11.64
Total Debt0
Total Debt/Equity0
Current Ratio5.11
Book Value Per Share12.66

Price History

52-Week Change26.24
52-Week High299.99
52-Week Low102.5
Moving Average 50 Days182.15
Moving Average 200 Days200.11

Statistics

Average Volume163,945
Shares Outstanding220.41M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor217:200
Last Split DateOctober 17, 2022